Breaking News, Collaborations & Alliances

Evotec, Centogene Enter Drug Discovery Collaboration

Sign global partnership on drug discovery projects in rare genetic diseases

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Centogene AG and Evotec have entered into a global strategic collaboration agreement for joint drug discovery projects focused on developing compounds to treat rare genetic diseases. Evotec and Centogene initiated the collaboration to develop a strategic high-throughput platform for testing novel small molecules in rare hereditary metabolic diseases. The collaboration brings together Evotec’s = induced pluripotent stem cell (iPSC) platform and broad drug discovery capabilities with C...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters